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Abstract
Background: Applying the switch from presumptive treatment of malaria to new policies of anti-malarial prescriptions 
restricted to parasitologically-confirmed cases is a still unsolved challenge. Pragmatic studies can provide data on 
consequences of such a switch. In order to assess whether restricting anti-malarials to rapid diagnostic test (RDT)-
confirmed cases in children of between five and 15 years of age is consistent with an adequate management of fevers, 
a school-based study was performed in Allada, Benin.
Methods: Children in the index group (with fever and a negative RDT) and the matched control group (without fever 
and a negative RDT) were not prescribed anti-malarials and actively followed-up during 14 days. Blood smears were 
collected at each assessment. Self-medication with chloroquine and quinine was assessed with blood spots. Malaria 
attacks during the follow-up were defined by persistent or recurrent fever concomitant to a positive malaria test.
Results: 484 children were followed-up (242 in each group). At day 3, fever had disappeared in 94% of children from 
the index group. The incidence of malaria was similar (five cases in the index group and seven cases in the control 
group) between groups. Self-medication with chloroquine and quinine in this cohort was uncommon.
Conclusions: Applying a policy of restricting anti-malarials to RDT-confirmed cases is consistent with an adequate 
management of fevers in this population. Further studies on the management of fever in younger children are of 
upmost importance.
Background
Presumptive treatment of fevers with chloroquine has
been formerly promoted in sub-Saharan malaria endemic
areas. Treatment with anti-malarials restricted to parasi-
tologically-confirmed cases is now promoted [1,2]. Dis-
crepancies between laboratory results and anti-malarials
prescriptions show that healthcare providers may not
trust blood smear results in routine practice [3-5].
Malaria rapid diagnostic tests (RDTs) have been adopted
as public heath policy in several African countries, but
some discrepancies between RDT results and anti-malar-
ial prescriptions are an unresolved critical issue [6-10].
Restricting anti-malarials to parasitologically-con-
firmed cases has been recommended in many countries
only for children of five years of age or above (provided
these children are less at risk for severe malaria); this dis-
crepancy between age groups in terms of guidelines [1]
on the management of fevers raises questions on the
rationale of this strategy [11,12]: if such a management of
uncomplicated fevers is reliable, why is it not applied also
to small children?
Providing that no diagnostic tool is perfect, collecting
prospectively data in order to show that applying recent
policies on the management of fever is safe and feasible
(i.e. does not lead to hospitalizations or death related to
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malaria, and does not frequently lead to undiagnosed
cases of uncomplicated malaria) is now very important.
The main objective of this school-based, prospective
cohort study was to collect clinical, parasitological and
pharmacological (self-medication) data in a pragmatic
approach in order to see whether, regardless of cost-effec-
tiveness issues, applying the algorithm on the manage-
ment of fevers is consistent with adequate clinical care.
Methods
Ethical statement
Ethical clearance was obtained from the Faculty of Medi-
cine ethics committee, Benin National University, Coto-
nou, and from the Deontology and Ethics Committee
from the Institute of Research for Development. Written
informed consent was obtained from all children or their
parents/guardians before enrolment in the study.
This study was designed to measure the incidence of
malaria attacks during a two-week follow-up period in
two populations of patients. First, an index group (with
fever) constituted by schoolchildren attending the school
nursery for fever and not diagnosed malaria, based on a
negative HRP2-based RDT. Second, a control group
(without fever) constituted of apparently healthy school-
children paired with index cases on gender, age, week of
inclusion and malaria status (i.e. negative HRP2-based
RDT).
Hence, the objective of the study was to assess whether
applying the algorithm of management of fevers in the
school setting is consistent with adequate management of
fevers, in the way it does not lead to a high number of
undiagnosed (and thus untreated) malaria attacks, and by
comparing the incidence of malaria attacks between the
two groups (with and without fever).
Study site
This study was performed from February through June
2008 (rains started in April) in four schools, located at
Allada, southern Benin, where malaria transmission is
intense and perennial [13]. Altogether, the four study
schools had a total of about 2,600 pupils of five years of
age and above.
Performance of the study
Children attended school nurseries on their own, or led
by their parents/guardians. Care was provided for any
child from a school participating to the study. Children
from the index group were included and actively followed
only if individual informed consent was obtained (within
24 hours from the initial visit) from a parent or guardian.
Asymptomatic children were screened for the control
group on gender, age, week of inclusion. The first child
with a negative RDT and for whom an informed consent
was obtained was included in the control group. Asymp-
tomatic children (screened for inclusion into the control
group) and with a positive RDT were advised to quickly
attend at the school nursery as soon as symptoms of
malaria would appear. Children treated for malaria within
the prior month were not included in either group.
All children were examined by a study nurse. Children
with danger signs were referred to a health centre. Chil-
dren attending the school nurseries were managed for
fever only if fever was stated (tympanic temperature at
37.8°C or above [14]) or if an history of fever in the pre-
ceding 24 hours was reported either by the child or his
parents/guardian. For each schoolchild managed for
fever, a RDT (Paracheck®, Orchid Diagnostics) [15] was
performed and children were given artemether-lumefan-
trine if the RDT result was positive, according to national
guidelines in this age group. At enrolment and during fol-
low-up, medications with anti-malarial activity for the
treatment of non-malarial illnesses were avoided when
acceptable alternatives were available.
Follow-up visits were on day 3, 7 and 14. A blood smear
was collected at enrolment and at each scheduled visit.
An additional blood spot for pharmacological data was
collected for 100 children in each group on day 0 and day
14. When fever was reported and/or stated at a follow-up
visit, a RDT was performed.
Laboratory analysis
RDTs were read by the study nurse, as recommended by
manufacturer 15 minutes after it was performed. A
Giemsa-stained thick blood film was prepared at inclu-
sion and at each follow-up visit. Microscopy examination
was done retrospectively (patients were managed accord-
ing to RDT results in terms of anti-malarials prescrip-
tions and assignment to the index group or the control
group) and blinded to the patient's identity. Parasite den-
sity was determined according to the number of parasites
per 200 white blood cells (WBC), and assuming a total
WBC count of 8,000/μL. Slide quality control was done
by masked re-reading of 10% of slides, selected randomly.
On day 0 and day 14 in the 100 first children from each
group, whole blood was sampled on filter paper spots and
dried at room temperature. Using these dried blood spot
(DBS), chloroquine (and monodesethylchloroquine) and
quinine were detected by high pressure liquid chroma-
tography with UV detection to 254 nm using ammonium
acetate (40 mM, pH = 5.5)/acetonitril (85/15% v/v) [16].
In order to find an explanation to false negative RDT
results, the exon 2 of pfhrp2  gene was amplified from
genomic DNA in corresponding isolates, by PCR using
the specific primer pairs Pfhrp2-F1 and Pfhrp2-R1 [17].
Statistics
Parametric tests (Pearson's chi-square and chi-square for
the comparison of crude rates [18] and non-parametric
(Fischer) tests were used.Faucher et al. Malaria Journal 2010, 9:104
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Results
Baseline data are presented in Figure 1 and Table 1. Half
of the children in the index group (124/242) had a tem-
perature at or above 37.8°C and 29% (71/242) had a tem-
perature at or above 38°C.
A total of 494 RDTs were performed in apparently
healthy children and 213 (43%) were positive. Among the
281 children who had a negative RDT, consent was
obtained in 242 for their participation into the study.
Most of them (62%) were prescribed an antibiotic and
paracetamol was widely used.
The median delay between inclusions in the index
group and in the control group was 0 day. In the index
group, blood smears were positive in 12 children (two
had a parasitaemia above 1,000 trophozoites: 3,572/μL
and 13,605/μL; one had a P. malariae parasitaemia). The
exon 2 of pfhrp2 gene was amplified with success ruling
out the hypothesis of pfhrp2 gene deletion to explain false
negative results.
Follow-up of index group children
Children of the index group were followed up a total of
465 person-weeks (Table 2). One child withdrew consent
on day 3. Three children withdrew because of declared
self-medication at home with an ACT. Six children were
lost to follow-up. At day 3, fever had disappeared in 94%
of children from the index group. Thirty-one episodes of
persistent or recurrent fever were observed in 30 children
during follow-up, 14 of them at or before day 3. An alter-
native diagnosis for fever was made during follow-up in
three cases (all treated with antibiotics with no anti-
malarial activity): two respiratory infections (day 1 and
day 14) and one tonsillitis (day 13).
When taking account solely cases of fever with a posi-
tive RDT, five malaria attacks were recorded (one at day 2,
two at day 3, one at day 7 and one at day 14) in five index
group children. No malaria severity or danger sign was
observed. At enrolment, two (malaria diagnosed at day 2
and day 14) had a positive blood smear (3,573/μL and
171/μL respectively).
Among the 12 children who had a positive blood smear
at baseline, three had malaria attacks (two when taking
into account solely cases of fever with a positive RDT)
during the follow-up. The nine other children never pre-
sented with fever during the follow-up; parasitaemia
spontaneously cleared in eight of these and remained
persistently low (<100/μL) in one child.
Follow-up of control group children
Children of the control group have been followed-up a
total of 477 person-weeks (Table 2). Three children were
lost to follow-up (one at day 3 and two at day 7), and no
child withdrew consent. Nineteen episodes of fever were
recorded during follow-up in 19 children, three of them
at or before day 3. A new diagnosis was established in
four cases (four respiratory infections), all treated with
antibiotics with no anti-malarial activity. RDT were not
performed in five of the 19 episodes of fever, but concom-
itant thick blood smears were negative.
When taking into account solely cases of fever with a
positive RDT, 7 malaria attacks (1 at day 3, 2 at day 7, 2 at
day 10, 1 at day 11 and 1 at day 14) were recorded in 7
children. At enrolment of these seven children, none had
a positive blood smear. Overall, one malaria attack was
not confirmed by microscopic examination. The clinical
picture in this case was stomatitis. Rates of self-medica-
tion did not differ between groups (Table 1).
Discussion
After decades of presumptive treatment strategies, the
restriction of anti-malarials to parasitologically-con-
firmed cases is necessarily difficult. Unfortunately, few
studies have dissected the consequences of applying the
algorithm of management of fever. Treating any fever in
children under five years of age with anti-malarials was
recommended in the study area. Therefore, only children
from the age of five years were included. The schoolchil-
dren in the study area were semi-immune and occurrence
of severe malaria was unlikely in this population, however
uncomplicated malaria may serve as a proxy for severe
malaria in less immune persons. Njama Meya et al [19]
used blood smears as a unique diagnosis tool to confirm
malaria, and subsequently passively followed-up children
(including children under the age of 5 years). They found
very few (0.8%) febrile illnesses related to malaria in the
seven days subsequent to visits for fever, in children who
were not treated with anti-malarials. Furthermore, these Figure 1 Profile of visits made to the study clinic.
Medical visits: 
 
1097 
Fever (declared and/or observed): 
 
677 (62%) 
Other reasons: 
 
420 (38%) 
Non malarial fevers (negative RDT): 
281 (42%) 
Malaria (positive RDT): 
396 (58%) 
Index Group: 
242 children 
Follow-up: 14 days 
 
respiratory infection (95), 
cutaneous infection (17), 
tonsillitis (17), mumps (15) 
pharyngitis (6), fever with rash (4), 
fever with diarrhoea (3), 
otitis (2), 
fever with dysenteria (2), 
sinusitis (1), stomatitis (1), 
chickenpox (1), 
unspecified (78) Faucher et al. Malaria Journal 2010, 9:104
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cases were uncomplicated and successfully treated. The
incidence of malaria in the seven days following a nega-
tive smear in febrile patients, was significantly lower than
the incidence of malaria in their entire cohort [19]. Msel-
lem et al [20] used RDTs in a situation of moderate to low
transmission intensity and conducted a cross-over clini-
cal trial of symptom-based clinical diagnosis versus clini-
cal diagnosis plus RDT. They followed patients actively at
day 14 and found a reduction of both perceived unsuc-
cessful care and anti-malarial prescription in the clinical
diagnosis plus RDT arm. The findings of these two stud-
ies support the policy of restricting anti-malarials to par-
asitologically-confirmed cases.
More malaria cases during follow-up were found in the
control group, but similar malaria incidence in the two
groups. Treating with an anti-malarial a child with fever
and a negative RDT seems not more useful than giving
the same treatment to an apparently healthy child. This
conclusion is based on the management of fever of 242
children, representing a patient flow of several months in
many health care facilities. Therefore, this study might be
underpowered to compare malaria incidence.
Malaria was the most frequent diagnosis (36% of all
medical visits) and no attack of severe malaria was
observed during follow-up, as this was expected in this
population of children. Since fever had disappeared in
94% of children from the index group, at day 3, educating
mothers to bring back their child after two or three days
in case of persistence of fever is, therefore, feasible: only a
small minority of mothers would have to come back to
the health care facility. Malaria attacks were not rare
among children with persistent or recurrent fever (five
out of 30) in the index group and in this case testing again
with a RDT when fever persists, rather than referring
patients directly, should be discussed.
The baseline status of the two groups was the negativity
of RDT. Interestingly, microscopically detectable parasi-
taemia at baseline, although rare in both groups, was
more frequent in the index group. Differences in terms of
self-medication can hardly explain these parasitological
differences between groups. Because chloroquine and
quinine were the most commonly drugs used for self-
medication in the study area, they were chosen as mark-
ers of self-medication, though other anti-malarials like SP,
were widely available at the time of the study.
As in previous studies [19,20], undiagnosed malaria
attacks at enrolment have lead to a few visits for persis-
tent or recurrent fever and once malaria was finally diag-
nosed, it was uncomplicated and successfully treated.
Two negative RDTs in children with a parasitaemia above
1,000/μL were observed. The inability of a diagnosis tool
to detect all malaria attacks may certainly be an obstacle
to full adherence of medical care providers to the algo-
rithm on the management of fevers. Providing that RDTs
are frequently positive in apparently healthy children in
endemic areas, life-threatening non-malarial causes of
Table 1: Characteristics of children, matched on gender, age, week of inclusion and rapid diagnostic test status.
Children characteristics IG CG p value
Sex, no. male/female 104/138 105/137 0.93
Age, years; n = 242 9,1 (2.5) 9,1 (2.5) 0.95
Body temperature, °C; n = 242 37.7 (0.7) 37.1 (0.3) < 10-5
Positive blood smear, day 0 12 (including 1 P. malariae); 
n = 242
3 (including 1 P. malariae); 
n = 236
0.02
Bednet use 54; n = 234 46; n = 238 0.32
Chloroquine detection day 0 13; n = 100 6; n = 99 0.1
Chloroquine detection day 14 7; n = 98 8; n = 98 0.79
Quinine detection day 0 1; n = 100 0; n = 99 _
Quinine detection day 14 0; n = 99 0; n = 98 _
Quantitative data are mean (SD). SD: Standard deviation; IG: index group; CG: control group.
Table 2: Malaria cases observed during follow-up in the whole cohort
Case definition (case 
numbers)
IG (242 patients) CG (242 children) p value
Fever + RDT 5 7 0.56
Fever + blood smear 6 5 0.76
IG: index group; CG: control group.Faucher et al. Malaria Journal 2010, 9:104
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fever may be concomitant to a detectable parasitaemia
and, therefore, a positive RDT may also be misleading.
Whether or not anti-malarials are prescribed at a medical
visit, the persistence of fever after two days must always
lead patients to present again to the outpatient clinic to
reassess the diagnosis.
Self-medication with quinine and chloroquine was
uncommon in this cohort of children who had access to
care, and it did not differ significantly between groups,
though there was a trend to more self-medication with
chloroquine at baseline in the index group.
Conclusions
Applying fully a policy of treatment of malaria restricted
to RDT-confirmed malaria cases appears to be consistent
with adequate management of fevers in this population.
Giving an anti-malarial treatment to a child with fever
and a negative RDT or to an apparently healthy child with
a negative RDT is equally useful. Further studies on the
management of fever in younger children are of upmost
importance.
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